BOLT vs V · rev $7.7M vs P/E 33, rev $40.00B
Bolt Biotherapeutics (BOLT) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
BOLT currently screens at market cap $11.3M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the BOLT and V stock pages for the full models.
Not investment advice.